Abstract

17
Background 18 Highly specialized cells work in synergy forming tissues to perform functions required for the survival 19 of organisms. Understanding this tissue-specific cellular heterogeneity and homeostasis is essential 20 to comprehend the development of diseases within the tissue and also for developing regenerative 21 therapies. Cellular subpopulations in the adipose tissue have been related to disease development, 22 but efforts towards characterizing the adipose tissue cell type composition are limited due to lack of 23 robust cell surface markers, limited access to tissue samples, and the labor-intensive process 24 required to identify them. 25
Results
26
We propose a framework, identifying cellular heterogeneity while providing state-of-the-art cellular 27 markers for each cell type present in tissues using transcriptomics level analysis. We validate our 28 approach with an independent dataset and present the most comprehensive study of adipose tissue 29 cell type composition to date, determining the relative amounts of 21 different cell types in 779 30 adipose tissue samples detailing differences across four adipose tissue depots, between genders, 31 across ranges of BMI and in different stages of type-2 diabetes. We also highlight the heterogeneity 32 in reported marker-based studies of adipose tissue cell type composition and provide novel cellular 33 markers to distinguish different cell types within the adipose tissue. 34
Background
42
The cell is the basic structural, functional, and biological unit of all living organisms. In multicellular 43 organisms, a wide variety of highly specialized cells that work in synergy form tissues to perform 44 functions required for the survival of the organism. The homeostasis in the system is maintained at 45 the cellular level as well, such that defective, old, damaged or infected cells, or cells that are harmful 46 to their environment either go through programmed cell death (apoptosis) or are actively detected 47 and killed by other feedback mechanisms such as the immune system. Hence, many molecular 48 sensors and inter-cellular mechanisms are evolved to ensure that the cellular heterogeneity is 49 maintained at the tissue level. 50
Adipose tissue (AT) is no exception in this regard. It is composed of adipocytes, immune system cells, 51 endothelial cells (blood and lymph vessels) and stem cells. Collectively, these cell types facilitate the 52 functions associated with the tissue as an endocrine organ, energy depot, and major player in energy 53 metabolism. To a large extent, it consists of adipocytes, which are commonly referred to as the fat 54 depots in the body. Furthermore, adipose tissue has the unique ability to expand and shrink in 55 significant proportions within the same individual over time. It can account for as little as 3% of total 56 body weight in elite athletes or as much as 70% in morbidly obese individuals [1] . 57
The conventional understanding of the adipose tissue portrays a fairly homogeneous tissue, 58 responding to higher energy intake by expanding and to lower energy intake by shrinking. In contrast 59
to this conventional belief, research in the last decade has focused on the different cellular 60 subpopulations in the adipose tissue and their relation to (metabolic) health and disease [2, 3] . This 61 research provided deeper insights into disease development and progression in complex diseases 62 (such as heart disease or diabetes) as well as inter-individual differences in disease etiology, paving 63 the way for improved subtyping of patients for targeted therapies. 64
However, so far the efforts towards characterizing the adipose tissue cell type composition are 65 limited, partially due to lack of robust cell surface markers identifying subpopulations of cells, but 66 also due to limited access to tissue samples and the labor-intensive process required to identify 67 them, such as immunohistochemistry or flow cytometry. Furthermore, the markers used to define a 68 subpopulation of cells within the adipose tissue can differ greatly across studies, impeding 69 reproducibility and leading to discrepancies across studies. Markers are usually defined for general 70 purpose, and not designed to be specific for a tissue, bringing in to question their specificity and 71 sensitivity. 72
In this paper, we propose a novel way of determining the adipose tissue cell type composition from 73 whole tissue gene expression profiles. Our proposed TissueDecoder framework builds upon a 74 recently published gene expression deconvolution algorithm [4] , and facilitates reuse of published 75 gene expression data for determining adipose tissue cell type composition across various depots and 76 phenotypic traits (Figure 1 In Figure 2A we show the correlations of signatures between the different cell types, revealing high 108 correlations between related cell types, such as subcutaneous and pericardial adipocytes, or 109 mesenchymal stromal cells, chondrocytes, osteoblasts, and adipose stem cells (ASCs). In this 110 analysis, we aim to evaluate the power of our approach to distinguish between similar cell types by 111 following two strategies. First, we apply the deconvolution approach to the reference dataset itself, 112 resulting in a clear distinction between cell types ( Figure 3C hematopoietic cell types such as monocytes or macrophages ( Figure 3A , Supplementary Figure S2 ).
152
The Dendrocyte Expressed Seven Transmembrane Protein (DCSTAMP) is identified as a very specific 153 primary marker for macrophages according to our analysis. In Figure 3B we observe that the high 154 expression of DCSTAMP is limited to a subset of the macrophage samples, which might highlight its 155 specificity to a subset of macrophages, e.g. macrophage giant like cells, as suggested by earlier 156 studies [9] . For ASCs and subcutaneous adipocytes, the identified primary markers (EEA1 and CMA1, 157 respectively) are not very striking. For these cell types, we suggest using a combination of secondary 158 markers as implemented in flow cytometry gating strategies as well as in CIBERSORT algorithm. 159
For further evaluation of the identified top primary markers, we compared their expression in a 160 more extensive independent dataset comprised of 394 anatomically annotated tissue expression 161 profiles (Supplementary Figure S3, The results of this analysis are presented in Supplementary Figure S4 and Supplementary Data S2, 180 showing that the primary markers are expressed and able to distinguish between cell types in the 181 validation dataset, with the exception of CMA1 for subcutaneous adipocytes and EEA1 for ASCs 182 (Supplementary Figure S4 B The results of the literature review are presented in Figure 4 and Supplementary Data S4. Reported 207 cell counts for macrophages vary greatly, ranging from average counts of less than 1% of total cells 208 in some studies up to an average of 27% of total cells in another study. These rather large 209 differences between the studies can arise due to several factors, including (i) actual biological 210 differences between the analyzed samples, (ii) local enrichment of macrophages (e.g. in crown-like 211 structures) that specifically influence results with low total cell counts like immunohistochemistry, 212 (iii) technical differences between the utilized methodologies and markers, (iv) differences in sample 213 handling and analysis protocols (e.g. fluorescence cutoffs, utilized antibodies), and (v) differences in 214 reported units across different studies. 215
It is important to note that specifically, some immunohistochemistry studies report very high 216 macrophage numbers ( Figure 4A ). In addition, there may be some differences due to reported units 217 across different studies, as the two studies with highest macrophage percentages (averages of 27% 218 and 26% macrophages) are the only ones reporting in 'macrophages per total number of nuclei'. We 219 have shown previously that immunohistochemistry studies from tissue slices can be biased due to 220 reliance on observations from cross-sections (thin tissue slices) [13] . Therefore, it can be argued that 221 specifically for adipocytes the cross-section may cover parts of the lipid droplet, but not the nucleus, 222 resulting in systematic differences between counting methodologies. 223
In order to evaluate the potential influence of biological differences between study participants, 224
especially with respect to their obesity status, we marked all studies involving people with an 225 average body mass index above 35 (severe obesity) with a star ( Figure 4A ). The relationship between 226 obesity status and macrophage counts has been studied in several articles, reporting increased 227 macrophage counts with increasing obesity in some, but not all studies [14] [15] [16] [17] [18] [19] . Nevertheless, the 228 obesity status cannot explain the observed diversity between reported macrophage percentages in 229 our literature review ( Figure 4A ). 230
For comparison, we assessed inter-study differences in our analyses (only SAT), showing relatively 231 stable results, which indicates a better standardization despite biological differences of study 232 participants and potential differences in sample handling between different labs (Supplementary 233 Figure S5 ). 234
In comparison to the literature reports, the estimated amount of macrophages from our analysis is 235 rather at the lower end, with an average of 1.3% of total cells for the 616 SAT samples (median of 236 0.8%, IQR: 0.03%-1.8%) and 1.2% of total cells for the 51 OAT samples (median of 1.2%, IQR: 0.4%-237 1.8%). Looking at the extreme values, our results confirm that there is a large range of macrophage 238 frequencies with up to 25% macrophages in very rare cases. 239
In order to account for the potential influence of monocytes, which also express the markers utilized 240 in the literature studies (CD14, CD68, and HAM56), we also report the combined fractions of 241 macrophages and monocytes from our AT21-CIBERSORT approach. by reporting their average cell type composition ( Figure 5 , detailed in Supplemental Figure S1 ). This 268
indicates that SAT has the highest percentage of adipocytes (74%) followed by OAT (66.4%), EAT 269 (59.5%) and PAT (59.4%), while EAT and PAT have far more immune cells (20.8% and 20.9%, 270 respectively) compared to OAT (9.8%) and SAT (7.4%). Furthermore, OAT is the richest source of 271 stem cells (17.2% compared to 14.9% for SAT, 14.1% for EAT and 12.4% for PAT). 272
These results need to be interpreted with care due to differences in number and characteristics of 273 people from which the samples were collected. Access to EAT and PAT is severely limited due to 274 their physiological location and the invasive nature of the sampling procedure. Therefore PAT 275 samples were taken from 66 patients (age: 66±8 years) with coronary artery disease (CAD) [24] and 276 the EAT samples were taken from 11 neonates (6 to 24 days old), 28 infants (40 days to 1 year-old) 277 and 7 children (2 to 7 years old) with congenital heart disease (CHD) [25] . 278
Despite differences in the age of EAT and PAT donors, the composition of the immune cell archetype 279 in EAT and PAT is remarkably similar to each other while being very different from SAT and OAT 280 samples. This indicates the robustness of our results as well as the conserved nature of the cell type 281 composition in these two adipose tissue depots surrounding the heart. 282
Furthermore, we report the fractions of classically designated "adaptive" immune cells, including B 283 cells, CD8 + and CD4 + T cells, infiltrated into EAT and PAT. These adaptive immune cells are enriched 284 in EAT and PAT, (higher in PAT than in EAT) compared to SAT and OAT depots, which could likely be 285 due to the origin of the analyzed samples from patients with CAD or CHD, as reported earlier for 286 CD8 + T cells [26] . Our finding is also supported by Mazurek and colleagues [27] , who compared the 287 expression of cytokines in both EAT and SAT in patients undergoing coronary artery bypass graft and 288 found that EAT is a source of several inflammatory mediators. 289
A more detailed comparison of SAT and OAT was performed on the study of Hardy et al 2011 290 (dataset GSE20950), in which both depots were available from the same individuals [18] . This 291 analysis revealed an increased neutrophil content in SAT (also after correcting for multiple testing) 292
and increased mesenchymal stromal cell and smooth muscle cell content in OAT ( Figure 6A ). are shown in Figure 6 and in more detail in Supplementary Figure S6 and Supplementary Data S5. 299
We detected significant differences in SAT cell composition between males and females, indicating 300
that Notably, there is a tendency towards higher amounts of ASCs and lower amounts of adipocytes in 315 heavier twins ( Figure 6C ), supporting the respective significant finding in the continuous association 316 with BMI. In contrast, some other findings of the continuous association with BMI are not detected 317 in the twin study, which can be attributed to potential confounding effects (age, gender, or other 318 factors) in the continuous association. 319
The lack of any significant results in the comparison of lean vs. obese children is mostly due to 320 limited power since the study only involves a total of 11 samples (5 obese and 6 lean children). 321
We made six comparisons related to diabetes, glucose tolerance, or insulin resistance. Figure 4B ) depending on the exact markers used to define the ASC phenotype as well as the 360 type of method used for isolating ASCs. In this study we robustly define the ASC signature based on 361 twenty one samples from three independent datasets and report that the ASC composition within 362 the adipose tissue can greatly vary from 3% to over 30% across individuals with the mean of 14.8% in 363 SAT (IQR: 12-17.2%) and 15.7% in OAT (IQR: 11.5-18.6%). This relatively large variation is potentially 364 due to the dynamic nature of the stem cell compartment as well as the broad spectrum of 365 individuals selected for this study. : E-MTAB-1895, GSE20950, GSE26637, GSE27657,  456  GSE27916, GSE27949, GSE40231, GSE41168, GSE66159, GSE71416, GSE82155, GSE9624;  457 Supplementary Data S2). 458
Raw data (CEL-files) were downloaded and preprocessed together with the reference dataset as 459 described above. Subsequently, CIBERSORT was used together with our custom AT21 signature 460 matrix to deconvolute the 779 samples, determining their relative cell type composition. This 461 allowed us to estimate the average cell type composition of four different adipose tissue depots 462 ( Figure 5 ) and to investigate associations between differences in adipose tissue cell type composition 463 and various phenotypes ( Figure 6 ). 464
Similarly, the deconvolution approach was applied to isolated cell types (reference dataset), to check 465 how well closely related cell types (e.g. subcutaneous and pericardial adipocytes) can be 466 distinguished ( Figure 3C ). 467
Statistics 468
Due to skewed distributions of relative cell type composition and a limited range of possible values 469 between 0 and 1, we used non-parametric (Wilcoxon) tests to evaluate the significance of 470 differences between phenotypes. Repeated measures within the same person (i.e. intervention 471 studies with placebo, resveratrol, or calorie restriction) as well as the twin study (heavier vs. leaner 472 twin concordant, heavier vs. leaner twin discordant) were considered as paired samples and 473 analyzed using Wilcoxon signed rank test. Non-paired comparisons were performed using Wilcoxon 474 rank sum test. Continuous analyses testing the association of age and BMI with adipose tissue cell 475 type composition were performed using permutation tests based on Spearman correlation ('cor.test' 476 function of package 'stats' in R). We report significant results both with and without Benjamini-477
Hochberg correction for multiple testing for the 336 comparisons (21 cell types times 16 phenotypic 478 traits). Reported p-values are without correction. 479
Cell type-specific marker detector (CellMaDe) 480
A classical approach to cell type identification is the use of antibodies for specific marker proteins in 481 immunohistochemistry or flow cytometry-based approaches. For these approaches, it is usually 482 necessary to know cell type-specific markers that are not expressed (or only much lower expressed) 483 in any of the other cell types. We refer to these markers as 'primary markers' in the manuscript. This 484 approach comes with the limitation that some cell types are difficult to distinguish based on the 485 expression of single marker proteins. For instance, mesenchymal stromal cells are typically 486 characterized by a combination of several markers as well as functional assays [37] . Thus, where 487 primary markers are not applicable, the idea is to combine several 'secondary markers' to receive 488 unambiguous cell type identification. 489
In CellMaDe, we define the 'primary criterion' and the 'secondary criterion' to determine primary 490 and secondary markers, respectively, as follows: 491
For each gene and each cell type, the primary criterion is calculated as the average expression of 492 that gene in this cell type, minus the largest average expression of that gene in any other cell type, 493
i.e. 494
where ̅̅̅̅ is the average expression of gene i in cell type j. The secondary criterion is calculated for 495 each gene and each cell type as the average expression of that gene in this cell type minus the 496 average expression of that gene in all other cell types, i.e. 497
This results in a primary criterion score and a secondary criterion score for each gene which are then 498 used to obtain the ranked lists for each score (Supplementary Figure S2) . 499
Identification of cellular compartments 500
We have also annotated the top ten primary markers and selected conventional markers with their 501 corresponding Gene Ontology (GO) cellular locations [38] in Fig 2b. Since these markers are 502 identified to be used potentially in cell sorting, identification, or tracking applications, they are 503 usually desired to be either on the cell surface, membrane or on the extracellular part of the 504 membrane. Hence, we have used four different notations depicting the locations of interest (M: 505 membrane, E: extracellular, ME: both membrane and extracellular, or O: other) for the 506 corresponding proteins ( Figure 2B , Supplemental Figure S2 ). 507
Evaluation of primary markers via Anatomically-annotated Tissue Expression Profiles 508
The definition of primary and secondary criteria defined in CellMaDe, depends on the cell types 509 included in the analysis arguably and therefore, can be considered (adipose) tissue-specific, provided 510 that all relevant cell types from the given tissue are included. Supplementary Data S2). The combined dataset is referred to as the "validation dataset". 531
The two datasets were downloaded (CEL files) and preprocessed together as described in section 532 deconvolution of adipose tissue cell types. Subsequently, we performed probe matching via the 533 biomaRt R package for platform transformation and quantile normalized the validation dataset with 534 the reference and analysis datasets form the Affymetrix Human U133 Plus 2.0 microarray. 535
The TissueDecoder framework is being used to calculate the percentages of the 21 cell types from 536 the AT21 signature matrix in the validation dataset and to evaluate the expression of conventional 537 markers as well as the primary markers reported from CellMaDe. The results are shown in 538
Supplementary Figure S4 . We converted all units into 566 percent of total cells using the formulas described below, excluding the two studies expressing the 567 cell numbers in number per high power field and number per mm 2 . 568
Unit conversion 569
Two studies reported cell counts (macrophages) as number per total number of nuclei, counted via 570 immunohistochemistry on tissue slices. We assumed that the number of anucleated cells in adipose 571 tissue is negligible and directly used the reported number as the percent of total cells. 572
The unit number per 100 adipocytes was used in six of the included studies that determined 573 macrophage frequency via immunohistochemistry. We converted the reported number (x) into 574 percent of total cells (y) via the formula 575 It is shown as a comparison, since the macrophage markers CD68, HAM56, and CD14 also stain monocytes. The gray dot in (B) represents the sum of 'supra adventitial-adipose stromal cells' (black dot in the same row) and 'endothelial progenitor cells', which were distinguished in the respective study, but are likely both covered in the 'adipose stem cell' score from our AT21 signature matrix. On the left hand side of each plot the references to the studies from which the results were taken (see Supplementary Data S4) and the utilized markers are indicated. For ASCs and endothelial cells a combination of markers was used (see Supplementary Data S4) and the CD206 marker in (A) was used in combination with CD14. A star attached to the study reference letter indicates that the study participant had an average body mass index above 35. It is included in the figure since it has been reported that the macrophage frequency is increased in people with severe obesity. , with the population distribution of the cell type percentages for the heavier vs leaner twin, discordant study. The y axis describes differences in estimated cell fractions between the heavier and leaner twin within a twin pair.
